Potassium levels in women with polycystic ovary syndrome using spironolactone for long-term.

Thais A deOliveiraLucas B MarchesanPoli Mara Spritzer

Published in: Clinical endocrinology (2023)

The present findings suggest that women with PCOS, without kidney or heart disease, using SPL combined with hormonal contraception for managing clinical hyperandrogenism have a low incidence of hyperkalemia and well-tolerated minor adverse effects.

Keyphrases

polycystic ovary syndrome
insulin resistance
risk factors
pulmonary hypertension
adipose tissue
metabolic syndrome
pregnant women